Top Markets
Coin of the day
Tauriga Sciences, Inc. Tauriga Sciences, Inc.

Tauriga Sciences, Inc.

TAUG
Rang in Aktien #42808
Tauriga Sciences, Inc. (TAUG) is primarily engaged in the manufacturing and... Tauriga Sciences, Inc. (TAUG) is primarily engaged in the manufacturing and distribution of its cannabidiol (CBD) infused chewing gum, sold under the brand name Tauri-Gum. The company also offers a diverse product portfolio, which includes a line of anti-nausea solutions. Its extensive collection of skincare items features CBD facemasks, daily moisturizers, anti-wrinkle creams (including specialized versions for dream, hand, and foot, often formulated with hemp seed oil), massage and body oils, body revive roll-ons, transdermal patches, and body sprays. Additionally, Tauriga Sciences provides a rainbow deluxe sampler pack, non-GMO CBD dietary supplements, and a variety of CBD-infused scented bath bombs. The firm distributes its merchandise through its e-commerce platform, various distributors, and wholesale channels. Notably, Tauriga Sciences has established a partnership with Aegea Biotechnologies, Inc. to collaborate on the development of a rapid, multiplex COVID-19 (novel coronavirus) diagnostic test. Established in 2001, the company maintains its corporate headquarters in Wappingers Falls, New York.
Aktienkurs
$0.000001
Zuletzt synchronisiert: 2023-08-11
Marktkapitalisierung
$56.43
Veränderung (1 Tag)
-90.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Tauriga Sciences, Inc. (TAUG)

Kategorie

P/B-Verhältnis für Tauriga Sciences, Inc. (TAUG)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Tauriga Sciences, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Tauriga Sciences, Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber